Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

San-Chi Chen

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Annals of Hepatology|May 19, 2026
Five years after IMbrave150 with clinical integration of atezolizumab plus bevacizumab in hepatocellular carcinomaKuan-Chang Lai, San-Chi Chen
Medicine|October 1, 2022
Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case reportYi-Hsuan Lai, Kai-Che Tung, San-Chi Chen
Journal of Biomedical Science|April 25, 2018
Emerging roles of epithelial-mesenchymal transition in hematological malignanciesSan-Chi Chen, Tsai-Tsen Liao, Muh-Hwa Yang
The Journal of Nursing Research : JNR|November 11, 2025
Changes in End-of-Life Quality in Patients With Terminal Cancer During Their Last 6 Months of Life: A Longitudinal StudyChen Hsiu Chen, San Chi Chen, Hsing Jung Lee
Frontiers in Immunology|September 19, 2022
Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and reviewKuan-Chang Lai, Yi-Han Hsiao, San-Chi Chen
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2025
Factors associated with end-of-life quality in terminally ill cancer patients' last six months of life: a longitudinal studyChen Hsiu Chen, San Chi Chen, Hsing Jung Lee
Journal for Immunotherapy of Cancer|July 18, 2018
Sick sinus syndrome associated with anti-programmed cell death-1Chien-Yi Hsu, Yu-Wen Su, San-Chi Chen
The Oncologist|April 20, 2016
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical StudySan-Chi Chen, Peter Mu-Hsin Chang, Muh-Hwa Yang
Frontiers in Oncology|October 3, 2025
Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: a case reportWei Chiu, San-Chi Chen, Yee Chao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 20, 2025
Complete Remission of Hepatocellular Carcinoma With Atezolizumab and Bevacizumab Following Prior B-cell DepletionJen-Pei Huang, Chun-Kuang Tsai, Pei-Ying Hsieh, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Annals of Hepatology|May 19, 2026
Five years after IMbrave150 with clinical integration of atezolizumab plus bevacizumab in hepatocellular carcinomaKuan-Chang Lai, San-Chi Chen
Medicine|October 1, 2022
Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case reportYi-Hsuan Lai, Kai-Che Tung, San-Chi Chen
Journal of Biomedical Science|April 25, 2018
Emerging roles of epithelial-mesenchymal transition in hematological malignanciesSan-Chi Chen, Tsai-Tsen Liao, Muh-Hwa Yang
The Journal of Nursing Research : JNR|November 11, 2025
Changes in End-of-Life Quality in Patients With Terminal Cancer During Their Last 6 Months of Life: A Longitudinal StudyChen Hsiu Chen, San Chi Chen, Hsing Jung Lee
Frontiers in Immunology|September 19, 2022
Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and reviewKuan-Chang Lai, Yi-Han Hsiao, San-Chi Chen
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2025
Factors associated with end-of-life quality in terminally ill cancer patients' last six months of life: a longitudinal studyChen Hsiu Chen, San Chi Chen, Hsing Jung Lee
Journal for Immunotherapy of Cancer|July 18, 2018
Sick sinus syndrome associated with anti-programmed cell death-1Chien-Yi Hsu, Yu-Wen Su, San-Chi Chen
The Oncologist|April 20, 2016
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical StudySan-Chi Chen, Peter Mu-Hsin Chang, Muh-Hwa Yang
Frontiers in Oncology|October 3, 2025
Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: a case reportWei Chiu, San-Chi Chen, Yee Chao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 20, 2025
Complete Remission of Hepatocellular Carcinoma With Atezolizumab and Bevacizumab Following Prior B-cell DepletionJen-Pei Huang, Chun-Kuang Tsai, Pei-Ying Hsieh, et al.
Pageof 7